Investigation of the mechanisms by which chronic infusion of an acutely subpressor dose of angiotensin II induces hypertension

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 5, 2007, Pages

  Hood, S G ^a   Cochrane, T ^a   McKinley, M J ^a   May, C N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Ganglion blockade; Losartan; Regional blood flow; Total peripheral resistance

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; HEXAMETHONIUM; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; DOSE RESPONSE; GANGLION BLOCK; HEART OUTPUT; HEART RATE; HYPERTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; PERIPHERAL CIRCULATION; PRESSOR RESPONSE; PRIORITY JOURNAL; SHEEP; SODIUM RETENTION; WATER RETENTION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HYPERTENSION; LOSARTAN; RECEPTOR, ANGIOTENSIN, TYPE 1; SHEEP;

EID: 34248194250     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00803.2006     Document Type: Article

References (40)

1. Abraham G, Simon G. Autopotentiation of pressor responses by subpressor angiotensin II in rats. Am J Hypertens 7: 269-275, 1994.
2. Ames RP, Borkowski AJ, Sicinski AM, Laragh JH. Prolonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, and aldosterone and cortisol secretion in normal man and in cirrhosis with ascites. J Clin Invest 44: 1171-1186, 1965.
3. Barrett CJ, Ramchandra R, Guild SJ, Lala A, Budgett DM, Malpas SC. What sets the long-term level of renal sympathetic nerve activity: a role for angiotensin II and baroreflexes? Circ Res 92: 1330-1336, 2003.
4. Bean BL, Brown JJ, Casals-Stenzel J, Fraser R, Lever AF, Millar JA, Morton JJ, Petch B, Riegger AJ, Robertson JI, Tree M. The relation of arterial pressure and plasma angiotensin II concentration. A change produced by prolonged infusion of angiotensin II in the conscious dog. Circ Res 44: 452-458, 1979.
5. Bickerton RJ, Buckley JP. Evidence for a central mechanism of angiotensin induced hypertension. Proc Soc Exp Biol Med 106: 834-836, 1961.
6. Brooks VL, Ell KR, Wright RM. Pressure-independent baroreflex resetting produced by chronic infusion of angiotensin II in rabbits. Am J Physiol Heart Circ Physiol 265: H1275-H1282, 1993.
7. Brown AJ, Casals-Stenzel J, Gofford S, Lever AF, Morton JJ. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol Heart Circ Physiol 241: H381-H388, 1981.
8. Bruner CA, Weaver JM, Fink GD. Sodium-dependent hypertension produced by chronic central angiotensin II infusion. Am J Physiol Heart Circ Physiol 249: H321-H327, 1985.
9. Carroll RG, Lohmeier TE, Brown AJ. Chronic angiotensin II infusion decreases renal norepinephrine overflow in conscious dogs. Hypertension 6: 675-681, 1984.
10. Cowley AW, DeClue JW. Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotension-induced hypertension in dogs. Circ Res 39: 779-787, 1976.
11. Cowley AW, McCaa RE. Acute and chronic dose-response relationships for angiotensin, aldosterone, and arterial pressure at varying levels of sodium intake. Circ Res 39: 788-797, 1976.
12. Cserep G, Abraham G, Tolins JP, Simon G. Different vascular responses to subpressor angiotensin II administration in the mesenteric and renal circulation of rats. Am J Hypertens 9: 385-392, 1996.
13. Dickinson CJ, Lawrence JR. A slowly developing pressor response to small concentrations of angiotensin. Its bearing on the pathogenesis of chronic renal hypertension. Lancet 1: 1354-1356, 1963.
14. Dickinson CJ, Yu R. Mechanisms involved in the progressive pressor response to very small amounts of angiotensin in conscious rabbits. Circ Res 21, Suppl 2: 157, 1967.
15. Edgley A, Kett M, Anderson W. "Slow pressor" hypertension from low-dose chronic angiotensin II infusion. Clin Exp Pharmacol Physiol 28: 1035-1039, 2001.
16. Fink GD, Bruner CA, Mangiapane ML. Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension 9: 355-361, 1987.
17. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17: 626-635, 1991.
18. Haywood JR, Fink GD, Buggy J, Phillips MI, Brody MJ. The area postrema plays no role in the pressor action of angiotensin in the rat. Am J Physiol Heart Circ Physiol 239: H108-H113, 1980.
19. Hendel MD, Collister JP. Contribution of the subfornical organ to angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 288: H680-H685, 2005.
20. Hendel MD, Collister JP. Renal denervation attenuates long-term hypertensive effects of angiotensin II in the rat. Clin Exp Pharmacol Physiol 33: 1225-1230, 2006.
21. King AJ, Fink GD. Chronic low-dose angiotensin II infusion increases venomotor tone by neurogenic mechanisms. Hypertension 48: 927-933, 2006.
22. Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens 4: 515-524, 1986.
23. Li Q, Dale WE, Hasser EM, Blaine EH. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. Am J Physiol Regul Integr Comp Physiol 271: R200-R207, 1996.
24. Lohmeier TE, Cowley AW Jr. Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog. Circ Res 44: 154-160, 1979.
25. Lohmeier TE, Hildebrandt DA. Renal nerves promote sodium excretion in angiotensin-induced hypertension. Hypertension 31: 429-434, 1998.
26. Lohmeier TE, Lohmeier JR, Warren S, May PJ, Cunningham JT. Sustained activation of the central baroreceptor pathway in angiotensin hypertension. Hypertension 39: 550-556, 2002.
27. Lowe RD, Scroop GC. The cardiovascular response to vertebral artery infusions of angiotensin in the dog. Clin Sci (Colch) 37: 593- 603, 1969.
28. Lumbers ER, McCloskey DI, Potter EK. Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol 294: 69-80, 1979.
29. Matsukawa S, Reid IA. Role of the area postrema in the modulation of the baroreflex control of heart rate by angiotensin II. Circ Res 67: 1462-1473, 1990.
30. May CN. Differential regional haemodynamic changes during mineralocorticoid hypertension. J Hypertens 24: 1137-1146, 2006.
31. May CN. Prolonged systemic and regional haemodynamic effects of intracerebroventricular angiotensin II in conscious sheep. Clin Exp Pharmacol Physiol 23: 878-884, 1996.
32. May CN, McAllen RM. Baroreceptor-independent renal nerve inhibition by intracerebroventricular angiotensin II in conscious sheep. Am J Physiol Regul Integr Comp Physiol 273: R560-R567, 1997.
33. McCubbin JW, DeMoura RS, Page IH, Olmsted F. Arterial hypertension elicited by subpressor amounts of angiotensin. Science 149: 1394-1395, 1965.
34. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FA, Chai SY. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35: 901-918, 2003.
35. Nahey D, Collister JP. ANG II-induced hypertension and the role of the area postrema during normal and increased dietary salt. Am J Physiol Heart Circ Physiol 292: H694-H700, 2007.
36. Osborn JL, Camara AK. Renal neurogenic mediation of intracerebroventricular angiotensin II hypertension in rats raised on high sodium chloride diet. Hypertension 30: 331-336, 1997.
37. Parkes DG, May CN. Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol 120: 1179-1185, 1997.
38. Simon G, Abraham G, Cserep G. Pressor and subpressor angiotensin II administration. Two experimental models of hypertension. Am J Hypertens 8: 645-650, 1995.
39. Simon G, Cserep G, Limas C. Development of structural vascular changes with subpressor angiotensin II administration in rats. Am J Hypertens 8: 67-73, 1995.
40. Watson AM, Lambert GW, Smith KJ, May CN. Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions. Hypertension 42: 373-379, 2003.